TORONTO, Nov. 8, 2018 /CNW/ - Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF; FRA:1QS) (the "Company" or "Pure Global" or "PURE"), an integrated, growth-oriented life sciences cannabis company, through its subsidiary PureSinse Inc. ("PureSinse"), is pleased to announce the readiness of eight product lines in eco-friendly packaging for medical cannabis patients.
PureSinse will begin sales to medical patients soon after Health Canada has granted it a Sales License, which is anticipated in the coming weeks. PureSinse is committed to providing medical cannabis patients with medical cannabis products despite the high demands of the legal adult markets, which also represents a higher margin sales channel for the Company.
The PureSinse product line, that includes eight stock keeping units (SKUs) of newly launched and co-branded products, is enhanced by the Company's commitment to a clinical and research-driven approach, true to its pharmacy and physician roots. With elegant sustainable packaging, PureSinse looks to provide its clientele with an exceptional customer experience at all levels of its service and product offerings.
Cheryl Pim, Director of New Product Development, says "the PureSinse brand is focused on patients. We will be tracking clinical outcomes through real-world studies to ensure our products lines are consistent, tailored and available. This consistency and dependability are what patients rely on for their medical needs. Our research and data-driven approach will ensure our products and methods also improve and evolve for the needs of patients over time."
Pure Global is also committed to reusable packaging and recyclable options and this "sets us apart," says Malay Panchal, CEO of Pure Global, "we have a plan to be sustainable and tightly linked to the clinical community. We are committed to outcomes that help patients on a consistent and ongoing basis."
About Pure Global Cannabis
Pure Global Cannabis Inc. (TSX.V:PURE; OTC:PRCNF; FRA:1QS) is an innovation-based cannabis Company led by experienced pharma, biotechnology, horticultural, consumer packaged goods (CPG), and supply chain experts. The Company's wholly owned subsidiary, PureSinse Inc., is a licensed producer under the Cannabis Act, 2018. The Company's Brampton campus houses facilities for vertically farmed cultivation, R&D, extraction, manufacturing, and distribution. PURE will produce branded and white-labeled cannabis products for the medical, pharmaceutical, wellness, health & beauty, natural health, food & beverage, and recreational legal markets with uniquely formulated and purified concentrates. The Company is using the Canadian market as a springboard to develop and manufacture GMP-compliant cannabis products for international sale and distribution with a goal to become one of the most trusted premium international cannabis brands.
This news release contains certain forward-looking statements, including, but not limited to, statements about Pure Global's future plans and intentions. Wherever possible, words such as "may", "will", "should", "could", "expect", "plan", "intend", "anticipate", "believe", "estimate", "predict" or "potential" or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect management's current beliefs and are based on information currently available to management as at the date hereof.
Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, Pure Global cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and Pure Global assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Pure Global Cannabis Inc.
For further information: Stephen Pynn, VP Corporate Development, Telephone: 1-866-899-PURE (7873), E-mail: firstname.lastname@example.org; Malay (Mel) Panchal, President & CEO, Telephone: 1-866-899-PURE (7873), E-mail: email@example.com